SCHEDULE 13D/A Filed 2026-04-28 Event 2026-04-28 SEC 0001104659-26-049902 →

GILEAD SCIENCES, INC. → Arcellx, Inc. ACLX

Stake: — Shares: 100 Class: Common Stock, par value $0.001

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-04-15

DTC 2.52

1,800,274 shares short · -20.7% vs prior

Other 13D/G Filings on Arcellx, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-30	SCHEDULE 13D/A	New Enterprise Associates 15, L.P.	—	0	view →
2026-04-28	SCHEDULE 13D/A	Elghandour Rami	—	0	view →
2025-02-27	SCHEDULE	Elghandour Rami	6.90%	3,997,132	view →
2023-12-18	SC	SR ONE CAPITAL MANAGEMENT, LLC	—	—	view →
2023-06-02	SC	SR ONE CAPITAL MANAGEMENT, LLC	—	—	view →
2023-01-24	SC	New Enterprise Associates 15, L.P.	—	—	view →
2022-06-27	SC	SR ONE CAPITAL MANAGEMENT, LLC	—	—	view →

Other Filings by GILEAD SCIENCES, INC.

Filed	Form	Issuer	Stake	Shares
2025-02-20	SCHEDULE	Arcus Biosciences, Inc. RCUS	35.00%	39,691,649	view →
2025-01-10	SCHEDULE	GALAPAGOS NV GLPGF	29.90%	20,981,010	view →
2024-06-20	SC	ASSEMBLY BIOSCIENCES, INC. ASMB	—	—	view →
2023-07-06	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2021-02-02	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2019-08-29	SC	GALAPAGOS NV GLPGF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →